Literature DB >> 11514569

Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.

M Wei1, S M Cohen, A P Silverman, S J Lippard.   

Abstract

The results presented describe the effects of various spectator ligands, attached to a platinum 1,2-intrastand d(GpG) cross-link in duplex DNA, on the binding of high mobility group box (HMGB) domains and the TATA-binding protein (TBP). In addition to cisplatin-modified DNA, 15-base pair DNA probes modified by [Pt(1R,2R-diaminocyclohexane)](2+), cis-[Pt(NH(3))(cyclohexylamine)](2+), [Pt(ethylenediamine)](2+), cis-[Pt(NH(3))(cyclobutylamine)](2+), and cis-[Pt(NH(3))(2-picoline)](2+) were examined. Electrophoretic mobility shift assays show that both the A and B domains of HMGB1 as well as TBP discriminate between different platinum-DNA adducts. HMGB1 domain A is the most sensitive to the nature of the spectator ligands on platinum. The effect of the spectator ligands on protein binding also depends highly on the base pairs flanking the platinated d(GpG) site. Double-stranded oligonucleotides containing the AG*G*C sequence, where the asterisks denote the sites of platination, with different spectator ligands are only moderately discriminated by the HMGB proteins and TBP, but the recognition of dsTG*G*A is highly dependent on the ligands. The effects of HMGB1 overexpression in a BG-1 ovarian cancer cell line, induced by steroid hormones, on the sensitivity of cells treated with [Pt(1R,2R-diaminocyclohexane)Cl(2)] and cis-[Pt(NH(3))(cyclohexylamine)Cl(2)] were also examined. The results suggest that HMGB1 protein levels influence the cellular processing of cis-[Pt(NH(3))- (cyclohexylamine)](2+), but not [Pt((1R,2R)-diaminocyclohexane)](2+), DNA lesions. This result is consistent with the observed binding of HMGB1a to platinum-modified dsTG*G*A probes but not with the binding affinity of HMGB1a and HMGB1 to platinum-damaged dsAG*G*C oligonucleotides. These experiments reinforce the importance of sequence context in platinum-DNA lesion recognition by cellular proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514569     DOI: 10.1074/jbc.M106374200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Authors:  C L King; S Ramachandran; S G Chaney; L Collins; J A Swenberg; K E DeKrafft; W Lin; L Cicurel; M Barbier
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

2.  Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

Authors:  Jaroslav Malina; Olga Novakova; Marie Vojtiskova; Giovanni Natile; Viktor Brabec
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

3.  Structural insights into the recognition of cisplatin and AAF-dG lesion by Rad14 (XPA).

Authors:  Sandra C Koch; Jochen Kuper; Karola L Gasteiger; Nina Simon; Ralf Strasser; David Eisen; Simon Geiger; Sabine Schneider; Caroline Kisker; Thomas Carell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

4.  Transcription inhibition by platinum-DNA cross-links in live mammalian cells.

Authors:  Wee Han Ang; MyatNoeZin Myint; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

5.  Chiral differentiation of DNA adducts formed by enantiomeric analogues of antitumor cisplatin is sequence-dependent.

Authors:  Olivier Delalande; Jaroslav Malina; Viktor Brabec; Jirí Kozelka
Journal:  Biophys J       Date:  2005-04-01       Impact factor: 4.033

Review 6.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

Review 7.  Satraplatin: leading the new generation of oral platinum agents.

Authors:  Ashish Bhargava; Ulka N Vaishampayan
Journal:  Expert Opin Investig Drugs       Date:  2009-11       Impact factor: 6.206

8.  Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.

Authors:  Yibing Wu; Debadeep Bhattacharyya; Candice L King; Irene Baskerville-Abraham; Sung-Ho Huh; Gunnar Boysen; James A Swenberg; Brenda Temple; Sharon L Campbell; Stephen G Chaney
Journal:  Biochemistry       Date:  2007-05-12       Impact factor: 3.162

9.  Differences in conformational dynamics of [Pt3(HPTAB)]6+-DNA adducts with various cross-linking modes.

Authors:  Yanyan Zhu; Yan Wang; Guangju Chen
Journal:  Nucleic Acids Res       Date:  2009-08-04       Impact factor: 16.971

10.  Cisplatin induces loop structures and condensation of single DNA molecules.

Authors:  Xi-Miao Hou; Xing-Hua Zhang; Kong-Ji Wei; Chao Ji; Shuo-Xing Dou; Wei-Chi Wang; Ming Li; Peng-Ye Wang
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.